Dr. Jenny Liu, DO

Dr. Liu practices at Silicon Valley Adult Day Health Care Center in Milpitas, California.

Dr. Liu's NPI, 1003444290, was assigned on April 1, 2020. Dr. Liu graduated from Lincoln Memorial University-DeBusk College of Osteopathic Medicine in 2020. Dr. Liu's Illinois license number on file is 125.075807.

Dr. Liu's primary practice is Silicon Valley Adult Day Health Care Center, at 631 S Milpitas Blvd, Milpitas, CA 95035 in Santa Clara County. The practice phone is (408) 719-1004.

Dr. Liu's primary practice is Silicon Valley Adult Day Health Care Center in Milpitas, California. Dr. Liu is also affiliated with Santa Clara Valley Medical Center. The medical group on file is County of Santa Clara Behavioral Health Services, Las Plumas Behavioral Health Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liu practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Liu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Liu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Liu's licenses on file in 2 states: Illinois and California.

Dmand AI lists aneurysm, chronic diabetes, chronic hypertension, coronary artery disease, insomnia, joint pain, peptic ulcer and underactive thyroid among the conditions Dr. Liu treats.

CMS data shows 26 Medicare services from Dr. Liu across 2 procedure codes in 2024, for 62 Medicare patients. Medicare paid $396 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Dr. Liu in 2024. The largest group is 65 to 74, with 33 patients. 65% of them have high blood pressure, and 48% have diabetes. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Liu's median patient age at 69, with 67% women.

In 2024, Dr. Liu wrote 3,314 Medicare Part D claims for 310 patients. 86% of them were for generic drugs. CMS names the drug for 2,665 of them, across 78 drugs with 11 or more claims each, at $272,036 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Liu for performance year 2024, reported as part of a group. Dr. Liu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Liu, published from 2009 to 2023. 2021 was the busiest year, with 7. The most frequent topics are Malaria, Nigeria and Commerce. Dr. Liu has published most often in PLoS One. Dr. Liu's most frequent co-authors are Jennifer I Hsuan Shen, MD, Michelle Sang Hsiang, MD and Jimee Hwang, MD.

Dmand AI links Dr. Liu to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 3 general payments to Dr. Liu from 2 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $33.

Dr. Liu graduated from Lincoln Memorial University-DeBusk College of Osteopathic Medicine in 2020.

Dr. Liu is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.